CervoMed
CRVO
37 hedge funds and large institutions have $5.42M invested in CervoMed in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
3% more funds holding
Funds holding: 36 → 37 (+1)
3.27% less ownership
Funds ownership: 19.11% → 15.85% (-3.3%)
22% less capital invested
Capital invested by funds: $6.97M → $5.42M (-$1.56M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$2.43M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$877K |
| 3 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
+$129K |
| 4 |
VF
Virtu Financial
New York
|
+$84.9K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$69.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.56M |
| 2 |
Millennium Management
New York
|
-$823K |
| 3 |
Renaissance Technologies
New York
|
-$252K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$152K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$58.9K |
CRVO Hedge Fund Activity: Q2 2026 in Review
37 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2026, worth a combined $5.42M — down 22% from $6.97M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CRVO positions and 5 closed out — a net gain of 2 holders — while 9 added to existing stakes and 8 trimmed.
The largest buyer was Woodline Partners, opening a new position worth an estimated $2.43M. The largest seller was Morgan Stanley, cutting an estimated $2.56M.
- 37 institutional investors held CervoMed (CRVO) as of Q2 2026, up from 36 in Q1 2026.
- Funds reported $5.42M of CervoMed stock for Q2 2026, down 22% quarter-over-quarter.
- 7 funds opened new CervoMed positions in Q2 2026 and 5 closed out, a net change of +2 holders.
- The largest CervoMed buyer in Q2 2026 was Woodline Partners, an estimated $2.43M added.
- The largest CervoMed seller in Q2 2026 was Morgan Stanley, an estimated $2.56M sold.
Based on aggregated 13F filings for Q2 2026.